Shanghai Renyoung Pharmaceutical Co., Ltd. is a professional manufacturer and trading company established in 2004 and headquartered in Shanghai, China. The company specializes in the research, development, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and plant extracts. With a workforce of 101 to 200 employees, including a dedicated R&D team, the company operates as a commercial bridge between domestic chemical factories and global pharmaceutical markets. Their core product portfolio includes Lumefantrine, Tigecycline, Febuxostat, and a wide range of specialized compounds such as steroids, peptides, SARMs, and CBD products. Renyoung Pharmaceutical maintains a strong focus on quality and compliance, holding certifications such as ISO 9001, GMP, CE, UL, and ASME. The company shares holdings in manufacturing facilities that feature cGMP-compliant workshops and synthesis capabilities ranging from laboratory to industrial scales. They offer comprehensive contract manufacturing services, including OEM, ODM, and custom synthesis for highly specialized chemical intermediates. Their global distribution network extends to over 40 countries across North America, Europe, Asia, and Africa, serving a diverse clientele with high-specification agrochemical ingredients, food additives, and dietary supplements.
Screw Air Compressor 10hp$3000
CNBIO SOLUTIONS
🇰🇷 South Korea
202011-50 peopleManufacturer/Trading Company
Product customization
Key market
Africa
Description
CNBIO SOLUTIONS is a manufacturer and trading company based in Yongin-si, Gyeonggi-do, Republic of Korea, specializing in dermatological advancements and aesthetic solutions. Established in 2020/2021, the company operates with 11-50 employees and focuses on improving how people look, feel, and live through innovative and ethical products. They are a contract manufacturer with a factory, offering OEM and ODM services. CNBIO SOLUTIONS specializes in hyaluronic dermal fillers and skin boosters, leveraging proprietary technology and advanced biotechnology. Their product portfolio includes injectable aesthetics, dermatological skincare, and skin treatments. Key products include MORAN Dermal Fillers (CUSHION, VOLUME, DENSITY types) and REJUNOS HA Dermal face filler, which are cross-linked HA with Lidocaine, available in various concentrations and sizes (1ml, 10ml pre-filled syringes, 50ml vials). These fillers are designed for various applications from superficial lines to deep wrinkles and augmentation, with effects lasting up to 18 months depending on the area. The company holds CE certifications, ensuring adherence to quality standards. CNBIO SOLUTIONS is committed to continuous R&D, including research into exosomes for skin regeneration, and aims to be a globally trusted and innovative aesthetics company.